---
schema_version: "secwatch.filing_event.v1"
accession: "0000805928-25-000006"
form_type: "8-K"
ticker: "AXGN"
cik: "0000805928"
company_name: "Axogen, Inc."
filed_at: "2025-01-10T23:59:59+00:00"
generated_at: "2026-05-28T05:58:31.703009+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Axogen reports Q4 2024 revenue $49.4M (+15.1% YoY); FY 2024 revenue $187.3M (+17.8%)

## Summary
- Q4 2024 revenue expected $49.4M, up 15.1% YoY; full-year 2024 revenue $187.3M, up 17.8%.
- Full-year gross margin expected above 75.5%; cash and investments $39.5M, up $2.5M from 2023.
- Growth driven by commercial execution in Extremities, OMF-Head & Neck, and Resensation adoption.
- Investor Day scheduled for March 4, 2025 to discuss strategic priorities.

## SEC filing metadata
- accession: 0000805928-25-000006
- form_type: 8-K
- ticker: AXGN
- cik: 0000805928
- company_name: Axogen, Inc.
- filed_at: 2025-01-10T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 2.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/805928/000080592825000006/0000805928-25-000006-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/805928/000080592825000006/axgn-20250110.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000805928-25-000006
- JSON: https://secwatch.observer/filing/0000805928-25-000006.json
- Plain text: https://secwatch.observer/filing/0000805928-25-000006.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.